Literature DB >> 2730165

Influence of non-steroidal anti-inflammatory drugs and disease activity on serum alkaline phosphatase concentrations in rheumatoid arthritis, osteoarthritis, and polymyalgia rheumatica.

A Doube1, J Davies, M Davis, P J Maddison.   

Abstract

The influence of non-steroidal anti-inflammatory drugs (NSAIDs) and of disease activity on the serum alkaline phosphatase concentration was examined in patients with rheumatoid arthritis, osteoarthritis, and polymyalgia rheumatica. Concentrations of serum alkaline phosphatase were similar both in patients with rheumatoid arthritis taking NSAIDs and in those not taking NSAIDs. In patients with osteoarthritis NSAID use was not associated with a significant increase in serum alkaline phosphatase. In rheumatoid arthritis no correlation was found between clinical indices of disease activity and serum alkaline phosphatase concentrations. There was significant correlation with plasma viscosity in rheumatoid arthritis, both in those taking and not taking NSAIDs, and in polymyalgia rheumatica. Serum alkaline phosphatase concentrations are not influenced by NSAIDs. Concentrations correlate with laboratory parameters, but not clinical indices of disease activity.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2730165      PMCID: PMC1003765          DOI: 10.1136/ard.48.5.368

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  8 in total

1.  Liver function tests and NSAIDs in rheumatoid arthritis.

Authors:  A Doube
Journal:  N Z Med J       Date:  1987-02-25

2.  Raised serum alkaline phosphatase in rheumatoid disease. An index of liver dysfunction?

Authors:  M J Kendall; R Cockel; J Becker; C F Hawkins
Journal:  Ann Rheum Dis       Date:  1970-09       Impact factor: 19.103

3.  Constrictive pericarditis in rheumatoid arthritis.

Authors:  A K Thould
Journal:  Ann Rheum Dis       Date:  1986-02       Impact factor: 19.103

4.  Liver disease in rheumatoid arthritis and Sjøgren's syndrome. Prospective study using biochemical and serological markers of hepatic dysfunction.

Authors:  J Webb; K Whaley; R N MacSween; G Nuki; W C Dick; W W Buchanan
Journal:  Ann Rheum Dis       Date:  1975-02       Impact factor: 19.103

5.  Gamma glutamyl transpeptidase levels in arthritis: a correlation with clinical and laboratory indices of disease activity.

Authors:  J R Lowe; M E Pickup; J S Dixon; P A Leatham; V M Rhind; V Wright; W W Downie
Journal:  Ann Rheum Dis       Date:  1978-10       Impact factor: 19.103

6.  Studies on the frequency and pathogenesis of liver involvement in rheumatoid arthritis.

Authors:  L Fernandes; S Sullivan; I G McFarlane; B M Wojcicka; T W Warnes; A L Eddleston; E B Hamilton; R Williams
Journal:  Ann Rheum Dis       Date:  1979-12       Impact factor: 19.103

7.  Liver function in some common rheumatic disorders.

Authors:  A Akesson; K Berglund; M Karlsson
Journal:  Scand J Rheumatol       Date:  1980       Impact factor: 3.641

8.  Liver disease in rheumatoid arthritis.

Authors:  P R Mills; R N MacSween; W C Dick; I A More; G Watkinson
Journal:  Scott Med J       Date:  1980-01       Impact factor: 0.729

  8 in total
  2 in total

Review 1.  Hepatitis and non-steroidal anti-inflammatory drugs.

Authors:  A Doube
Journal:  Ann Rheum Dis       Date:  1990-07       Impact factor: 19.103

2.  Alkaline phosphatase isoenzyme activities in rheumatoid arthritis: hepatobiliary enzyme dissociation and relation to disease activity.

Authors:  S Aida
Journal:  Ann Rheum Dis       Date:  1993-07       Impact factor: 19.103

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.